METiS Pharmaceuticals
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 Cambridgepark Dr, Cambridge, Massach...Website
www.metistechbio.comRevenue
$9.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About METiS Pharmaceuticals
Founded in 2020, METiS Pharmaceuticals is a biotechnology company utilizing artificial intelligence (AI) to enhance drug delivery and discovery. By integrating advanced AI with traditional pharmaceutical research and development, METiS Pharmaceuticals aims to accelerate the creation of effective drugs and support the pharmaceutical ecosystem. The company leverages core technology platforms to drive industry innovation.Explore more
METiS Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is METiS Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if METiS Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when METiS Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Check out if METiS Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once METiS Pharmaceuticals has new funding data
METiS Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on METiS Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at METiS Pharmaceuticals
Click to see if METiS Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
METiS Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
METiS Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about METiS Pharmaceuticals.
METiS Pharmaceuticals financials insights
Gather financial insights about METiS Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series C
$100M
2025
Series D
$55.7M
METiS Pharmaceuticals Tech Stack
A closer look at the technologies used by METiS Pharmaceuticals
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
Executive Moves, Seeking Replacement
Funding
Funding
Funding
METiS Pharmaceuticals News & Media
METiS Pharmaceuticals Appoints Mark Herbert as Chief Business Officer
HANGZHOU, China, March 3, 2025 /PRNewswire/ -- METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery technologies, today announced the appointment of Mark Herbert as Chief Business Officer (CBO), effective January 22, 2025. In this role, Mr. Herbert will lead global business development, build key partnerships, and explore new opportunities to support METiS' growth and advance the commercialization of its drug delivery technologies. METCICC Capital leads METiS's Series C round and 25 other Greater China deals worth $420m
The firm counts HongShan (previously Sequoia Capital China); Source Code Capital; and Monolith Management, among some of its backers.METiS Joins the Roche Accelerator
CAMBRIDGE, Mass.--(BUSINESS WIRE)--METiS announces that it is officially joining the Roche AcceleratorMETiS Therapeutics Appoints Hongming Chen, Sc.D., President and Head of Research ... - BioSpace
METiS Therapeutics Appoints Hongming Chen, Sc.D., President and Head of Research & Development - read this article along with other careers information, tips and advice on BioSpace
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding METiS Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Founded in 2020, METiS Pharmaceuticals is a biotechnology company utilizing artificial intelligence (AI) to enhance drug delivery and discovery. By integrating advanced AI with traditional pharmaceutical research and development, METiS Pharmaceuticals aims to accelerate the creation of effective drugs and support the pharmaceutical ecosystem. The c... Read More
